| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |